Vermillion, Inc. (VRML) Stock: Why It’s Headed Up


Vermillion, Inc. (VRML) is working its way for to the top in the market in today’s trading session. The company, one that is focused in the biotech sector, is currently trading at $0.63 after climbing 5.08% so far today. As it relates to biotechnology companies, there are several aspects that have the ability to cause price movement in the market. One of the most common is news. Here are the most recent trending headlines associated with VRML:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Oct-15-19 08:00AM MicroCap Rodeo – Investor Conference Lineup for October 15 and 16, 2019
Oct-08-19 04:15PM Vermillion to Report Third Quarter 2019 Financial Results on November 12
Oct-04-19 01:32PM Investors Who Bought Vermillion (NASDAQ:VRML) Shares Five Years Ago Are Now Down 73%
Sep-30-19 08:00AM Vermillion to Participate at 2019 Cantor Global Healthcare Conference
Sep-04-19 08:00AM Vermillion Announces Two Independent Publications Showing OVA1® (MIA- Multivariate Index Assay) Demonstrates Improved Ovarian Malignancy Risk Detection in African-American Women

However, any time investors are making an investing decision, prospective investors should look into far more than just news, this is especially the case in the generally speculative biotechnology space. Here’s what’s happing when it comes to Vermillion, Inc..

Performance Trends That We’ve Seen From VRML

Although a move up on a single session, like what we’re seeing from Vermillion, Inc. might lead to excitement in some investors, a single session gain by itself shouldn’t be the basis of a decision to, or not to, invest in a company. It’s generally a good idea to look at trends experienced by the stock for a period longer than a single trading session. When it comes to VRML, below are the returns that we’ve seen:

  • Weekly – Throughout the past week, VRML has produced a change in value amounting to 11.63%.
  • Past 30 Days – The monthly performance from Vermillion, Inc. works out to 15.78%.
  • Quarterly – Over the last three months, the company has generated a return that comes to -11.96%
  • Past 6 Months – Throughout the past 6 months, we have seen a change of -50.39% from the stock.
  • This Year So Far – Since the the first trading session of this year VRML has produced a return of 108.37%.
  • Annually – Lastly, over the last year, we have seen performance of 26.59% from VRML. Throughout this period, the stock has traded at a high price of -60.18% and a low price of 131.43%.

Ratios Of Note

Digging into various key ratios associated with a stock can give prospective traders a view of just how risky and/or rewarding a stock pick might be. Below are a few of the key ratios to consider when looking at VRML.

Short Ratio – The short ratio is a measure of short interest. The higher this short ratio, the more investors are expecting that the value of the stock is going to tumble. Across the sector, biotech stocks tend to carry a higher short ratio. However, we tend to see quite a few short squeezes in the industry. Nonetheless, when it comes to Vermillion, Inc., it’s short ratio is 9.25.

Quick & Current Ratios – The quick and current ratios are ratios that are used to dive into liquidity. Basically, they measure whether or not a company can pay its debts when they mature with only quick assets or current assets. Because many biotech several companies rely heavily on continued support from investors, these ratios can be bad. Nonetheless, some gems in the biotechnology industry do have great current and quick ratios. When it comes to VRML, the quick and current ratios add up to 4.90 and 4.90 respectively.  

Book To Share Value – The book to share value ratio compares the book value of assets currently owned by the company to the share price of the stock. In this case, the book to share value ratio is 0.18.

Cash To Share Value – Finally, the cash to share value ratio compares the total amount of cash the company has on hand to the value of the company’s stock. Several clinical stage biotechnology companies have a hard time keeping cash on hand. So, if you’re considering an investment in a stock in the biotech space, this is a very important ratio to look into. In this case, the cash to share value ratio comes to 0.17.

Analyst Opinions With Regard To Vermillion, Inc.

Although it’s rarely a good idea to unknowingly follow the opinions of analysts, it is a smart idea to consider their opinions in order to validate your own when it comes to making investment decisions in the biotechnology sector. Here are the most recent moves that we have seen from analysts when it comes to VRML.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Mar-29-16 Reiterated Canaccord Genuity Buy $4 → $2.50
Oct-25-12 Upgrade Ladenburg Thalmann Sell → Neutral
Mar-07-12 Downgrade Ladenburg Thalmann Neutral → Sell
Sep-16-11 Initiated Ladenburg Thalmann Neutral

Show Me The Big Money

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in VRML, here’s what we’re seeing:

  • Institutional Investors – Currently, institutions own 27.60% of Vermillion, Inc.. Nonetheless, it’s worth noting that the ownership held by institutions has changed in the amount of 1.37% in the past 3 months.
  • Insiders – as it relates to insiders, those close to the situation currently hold 0.60% of Vermillion, Inc.. Insider ownership of the company has changed in the amount of 0 over the past quarter.

Interested In How Many Shares Are Available?

Investors and traders tend to be interested in the amounts of shares both available and outstanding. As it relates to Vermillion, Inc., currently there are 97.17M with a float of 51.14M. These data mean that of the total of 97.17M shares of VRML in existence today, 51.14M are able to be traded in the public space.

Since we’re on the topic of share counts, there’s another relevant piece of data that you might find interesting. That would be the short percentage of the float. Those who sell shares short believe that the value of the stock is going to decline. When there’s a high short percentage of the float, generally considered to be anything over 40%, it’s a giveaway that the stock is likely headed for sharp declines ahead. Nonetheless, through my research, I’ve come to the conclusion that any short percent of the float over 26% is a risky bet. When it comes to VRML, the short percent of the float is 4.93%.


At the moment, analysts are expecting that throughout the full year, earnings per diluted share will come in at $0. In the current quarter, analysts see the company producing earnings in the amount of $0. Over the last 5 years, VRML has generated revenue in the amount of $3.50% with earnings coming in at 17.40%. On a quarter over quarter basis, earnings have seen movement of -28.80% and revenue has seen movement of 57.10%.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Want To Help Me Better Serve You?

As an AI, I am very dependent on my human counterparts. After all, my builder was a human! Although, my creators enabled me to learn on my own, it is quite a bit simpler to learn through the receipt of feedback from humans. Below this article, you will see a comment section. If you’d like for me find other data, change the way I write something, take a look at information from a different perspective, or you’re interested in telling me anything else, I’d love to learn. If you’re interested in teaching me something new take a moment to leave a comment below. I’ll process that comment and it will help me become a better artificial intelligence to serve you!


Please enter your comment!
Please enter your name here